1st Quarter - Report

EMERGENT BIOSOLUTIONS INC. for EMERGENT BIOSOLUTIONS INC

Period 1st Quarter 2009 Filed Apr 20, 2009 Signed by Allen M. Shofe, Senior Vice President, Public Affairs

Official filing
Firm
EMERGENT BIOSOLUTIONS INC.
Client
EMERGENT BIOSOLUTIONS INC
Income
—
Expenses
$740,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Homeland Security HOM

H.R. 1105 Omnibus Appropriations Act 2009, Departments of Labor, Health and Human Services and Education 2009- all provisions relating to the development, acquisition and stockpiling of biodefense vaccines; H.R. 1 and S.1 American Recovery & Reinvestment Act of 2009 - provisions relating to biodefense funding

LobbyistCovered position, as disclosed
ASHLEY BRATICH —
CHRIS FRECH New Deputy Assistant to the President for Leg Affairs
ALLEN SHOFE —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Defense, Dept of (DOD); Homeland Security, Dept of (DHS)

Bills named: H.R. 1 (111th), H.R. 1105 (111th), S. 1 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.